title: Special comments - Neonatal Intensive Care Drug Manual
text: 1. Wade KC. et al. (2008) Population Pharmacokinetics of Fluconazole in Young Infants, Antimicrobial Agents and Chemotherapy, vol.52; 11, p. 4043–4049.
  2. Wade KC. et al. (2009) Fluconazole Dosing for the Prevention or Treatment of Invasive Candidiasis in Young Infants, The Paediatric Infectious Disease Journal, vol. 28; 8, 717–723.
  3. Saxen H. et al.(1993) Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life, Clinical Pharmacology & Therapeutics, vol. 53; 3, 269–277.
  4. Wenzl TG. et al. (1998) Pharmacokinetics of oral fluconazole in premature infants, Eur J Pediatr, 157:661–662.
  5. Nahata MC, Tallian KB, Force RW. Pharmacokinetics of fluconazole in young infants. Eur J Drug Metab Pharmacokinet. 1999;24(2):155–157.
  6. Takemoto CK et al. (2013) Pediatric & Neonatal Dosage Handbook 20th Edition, page 795–798
  7. Trissel’s IV Compatibility, accessed 04/08/2015 via Micromedex 2.0
  8. Society of Hospital Pharmacists of Australia (2015) Australian Injectable Drugs Handbook 6th Edition, Fluconazole Monograph.
  9. MIMs Product Information Fluconazole Sandoz Injection Product Information, Sandoz. MIMS online. Accessed on 13 January 2021
  10. Micromedex solutions. Accessed on 29th July 2015.
  |